[
Amado LC, Saliaris AP, Raju SVY, Lehrke S, St John M, Xie J, Stewart G, Fitton T, Minhas KM, Brawn J, Hare JM. Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure. J Mol Cell Cardiol 39, 531–536, 2005.10.1016/j.yjmcc.2005.04.008
]Search in Google Scholar
[
Antunes F, Han D, Cadenas E. Relative contributions of heart mitochondria glutathione peroxidase and catalase to H(2)O(2) detoxification in in vivo conditions. Free Radic Biol Med 33, 1260–1267, 2002.10.1016/S0891-5849(02)01016-X
]Search in Google Scholar
[
Bai T, Wang F, Zheng Y, Liang Q, Wang Y, Kong J, Cai L. Myocardial redox status, mitophagy and cardioprotection: a potential way to amend diabetic heart? Clin Sci (Lond), 130, 1511–1521, 2016.10.1042/CS2016016827433024
]Search in Google Scholar
[
Bernatoniene J, Kopustinskiene DM, Jakstas V, Majiene V, Baniene R, Kursvietiene L, Masteikova R, Savickas A, Toleikis A, Trumbeckaite S. The effect of Leonurus cardiaca herb extract and some of its flavonoids on mitochondrial oxidative phosphorylation in the heart. Planta Med 80, 525–532, 2014.10.1055/s-0034-136842624841965
]Search in Google Scholar
[
Bowe JE, Franklin ZJ, Hauge-Evans AC, King AJ, Persaud SJ, Jones PM. Metabolic phenotyping guidelines: assessing glucose homeostasis in rodent models. J Endocrinol 222, G13–G25, 2014.10.1530/JOE-14-018225056117
]Search in Google Scholar
[
Brown DI, Griendling KK. Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ Res 116, 531–549, 2015.10.1161/CIRCRESAHA.116.303584439238825634975
]Search in Google Scholar
[
Cao H, Pauff JM, Hille R. X-ray crystal structure of a xanthine oxidase complex with the flavonoid inhibitor quercetin. J Nat Prod 77, 1693–1699, 2014.10.1021/np500320g25060641
]Search in Google Scholar
[
Cave A, Grieve D, Johar S, Zhang M, Shah AM. NADPH oxidase-derived reactive oxygen species in cardiac patho-physiology. Philos Trans R Soc Lond B Biol Sci 360, 2327–2334, 2005.10.1098/rstb.2005.1772156959916321803
]Search in Google Scholar
[
Conti G, Caccamo D, Siligato R, Gembillo G, Satta E, Pazzano D, Carucci N, Carella A, Del Campo G, Salvo A, Santoro D. Association of higher advanced oxidation protein products (AOPPs) levels in patients with diabetic and hypertensive nephropathy. Medicina (Kaunas) 55, 675, 2019.10.3390/medicina55100675684392031591338
]Search in Google Scholar
[
Daubney J, Bonner PL, Hargreaves AJ, Dickenson JM. Cardioprotective and cardiotoxic effects of quercetin and two of its in vivo metabolites on differentiated h9c2 cardiomyocytes. Basic Clin Pharmacol Toxicol 116, 96–109, 2015.10.1111/bcpt.1231925203460
]Search in Google Scholar
[
Di Lisa F, Menabo R, Barbato R, Siliprandi N. Contrasting effects of propionate and propionyl-L-carnitine on energy-linked processes in ischemic hearts. Am J Physiol 267, 455–461, 1994.10.1152/ajpheart.1994.267.2.H4558067396
]Search in Google Scholar
[
D’Oria R, Schipani R, Leonardini A, Natalicchio A, Perrini S, Cignarelli A, Laviola L, Giorgino F. The role of oxidative stress in cardiac disease: from physiological response to injury factor. Oxid Med Cell Longev 2020, 5732956, 2020.10.1155/2020/5732956724497732509147
]Search in Google Scholar
[
Dudylina AL, Ivanova MV, Shumaev KB, Ruuge EK. Superoxide formation in cardiac mitochondria and effect of phenolic antioxidants. Cell Biochem Biophys 77, 99–107, 2019.10.1007/s12013-018-0857-230218405
]Search in Google Scholar
[
Eid HM, Haddad PS. The antidiabetic potential of quercetin: underlying mechanisms. Curr Med Chem 24, 355–364, 2017.10.2174/092986732366616090915370727633685
]Search in Google Scholar
[
Gauer JS, Tumova S, Lippiat JD, Kerimi A, Williamson G. Differential patterns of inhibition of the sugar transporters GLUT2, GLUT5 and GLUT7 by flavonoids. Biochem Pharmacol 152, 11–20, 2018.10.1016/j.bcp.2018.03.01129548810
]Search in Google Scholar
[
Ghorbani A, Rashidi R, Shafiee-Nick R. Flavonoids for preserving pancreatic beta cell survival and function: a mechanistic review. Biomed Pharmacother 111, 947–957, 2019.10.1016/j.biopha.2018.12.12730841474
]Search in Google Scholar
[
Gorbenko NI, Borikov OY, Ivanova OV, Taran KV, Litvinova TS, Kiprych TV, Shalamai AS. The effect of quercetin on oxidative stress markers and mitochondrial permeability transition in the heart of rats with type 2 diabetes. Ukr Biochem J 91, 46–54, 2019.10.15407/ubj91.05.046
]Search in Google Scholar
[
Gradinaru D, Borsa C, Ionescu C, Margina D. Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes. J Proteomics 92, 313–322, 2013.10.1016/j.jprot.2013.03.03423587667
]Search in Google Scholar
[
Huynh K, Bernardo BC, McMullen JR, Ritchie RH. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther 142, 375–415, 2014.10.1016/j.pharmthera.2014.01.00324462787
]Search in Google Scholar
[
Huynh K, Kiriazis H, Du XJ, Love JE, Gray SP, Jandeleit-Dahm KA, McMullen JR, Ritchie RH. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice. Free Radic Biol Med 60, 307–317, 2013.10.1016/j.freeradbiomed.2013.02.02123454064
]Search in Google Scholar
[
International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: 2019. Available at: https://www.diabetesatlas.org.
]Search in Google Scholar
[
Jimenez R, Lopez-Sepulveda R, Romero M, Toral M, Cogolludo A, Perez-Vizcaino F, Duarte J. Quercetin and its metabolites inhibit the membrane NADPH oxidase activity in vascular smooth muscle cells from normotensive and spontaneously hypertensive rats. Food Funct 6, 409–414, 2015.10.1039/C4FO00818A
]Search in Google Scholar
[
Kayama Y, Raaz U, Jagger A, Adam M, Schellinger IN, Sakamoto M, Suzuki H, Toyama K, Spin JM, Tsao PS. Diabetic cardiovascular disease induced by oxidative stress. Int J Mol Sci 16, 25234–25263, 2015.10.3390/ijms161025234
]Search in Google Scholar
[
Kicinska A, Jarmuszkiewicz W. Flavonoids and mitochondria: activation of cytoprotective pathways? Molecules 25, 3060, 2020.10.3390/molecules25133060
]Search in Google Scholar
[
Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. ScientificWorldJournal 2013, 162750, 2013.10.1155/2013/162750
]Search in Google Scholar
[
Lagoa R, Graziani I, Lopez-Sanchez C, Garcia-Martinez V, Gutierrez-Merino C. Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria. Biochim Biophys Acta 1807, 1562–1572, 2011.10.1016/j.bbabio.2011.09.022
]Search in Google Scholar
[
Lee MC, Velayutham M, Komatsu T, Hille R, Zweier JL. Measurement and characterization of superoxide generation from xanthine dehydrogenase: a redox-regulated pathway of radical generation in ischemic tissues. Biochemistry 53, 6615–6623, 2014.10.1021/bi500582r
]Search in Google Scholar
[
Li JM, Gall NP, Grieve DJ, Chen M, Shah AM. Activation of NADPH oxidase during progression of cardiac hyper-trophy to failure. Hypertension 40, 477–484, 200210.1161/01.HYP.0000032031.30374.32
]Search in Google Scholar
[
Lin S, Yang J, Wu G, Liu M, Luan X, Lv Q, Zhao H, Hu J. Preventive effect of taurine on experimental type II diabetic nephropathy. J Biomed Sci 17 (Suppl 1), S46, 2010.10.1186/1423-0127-17-S1-S46
]Search in Google Scholar
[
Liu Q, Wang S, Cai L. Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage. J Diabetes Invest 5, 623–634, 2014.10.1111/jdi.12250
]Search in Google Scholar
[
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265–275, 1951.10.1016/S0021-9258(19)52451-6
]Search in Google Scholar
[
Lutz M, Fuentes E, Avila F, Alarcon M, Palomo I. Roles of phenolic compounds in the reduction of risk factors of cardiovascular diseases. Molecules 24, 366, 2019.10.3390/molecules24020366635932130669612
]Search in Google Scholar
[
Miller GL. Protein determination for large number of samples. Anal Chem 31, 964, 1959.10.1021/ac60149a611
]Search in Google Scholar
[
Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284, 13291–13295, 2009.10.1074/jbc.R900010200267942719182219
]Search in Google Scholar
[
Peoples JN, Saraf A, Ghazal N, Pham TT, Kwong JQ. Mitochondrial dysfunction and oxidative stress in heart disease. Exp Mol Med 51, 1–13, 2019.10.1038/s12276-019-0355-7692335531857574
]Search in Google Scholar
[
Pereira DF, Cazarolli LH, Lavado C, Mengatto V, Figueiredo MS, Guedes A, Pizzolatti MG, Silva FR. Effects of flavonoids on α-glucosidase activity: potential targets for glucose homeostasis. Nutrition 27, 1161–1167, 2011.10.1016/j.nut.2011.01.00821684120
]Search in Google Scholar
[
Raza H, John A. Glutathione metabolism and oxidative stress in neonatal rat tissues from streptozotocin-induced diabetic mothers. Diabetes Metab Res Rev 20, 72–78, 2004.10.1002/dmrr.42214737748
]Search in Google Scholar
[
Redondo A, Estrella N, Lorenzo AG, Cruzado M, Castro C. Quercetin and catechin synergistically inhibit angiotensin II-induced redox-dependent signalling pathways in vascular smooth muscle cells from hypertensive rats. Free Radic Res 46, 619–627, 2012.10.3109/10715762.2012.66052722295890
]Search in Google Scholar
[
Ritchie RH, Abel ED. Basic mechanisms of diabetic heart disease. Circ Res 126, 1501–1525, 2020.10.1161/CIRCRESAHA.120.315913725197432437308
]Search in Google Scholar
[
Ritchie RH, Quinn JM, Cao AH, Drummond GR, Kaye DM, Favaloro JM, Proietto J, Delbridge LMD. The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo. J Mol Cell Cardiol 42, 1119–1128, 2007.10.1016/j.yjmcc.2007.03.90017490678
]Search in Google Scholar
[
Sagor AT, Tabassum N, Potol A, Alam A. Xanthine oxidase inhibitor, allopurinol, prevented oxidative stress, fibrosis, and myocardial damage in isoproterenol induced aged rats. Oxid Med Cell Longev 2015, 478039, 2015.10.1155/2015/478039447555026137187
]Search in Google Scholar
[
Salehi B, Machin L, Monzote L, Sharifi-Rad J, Ezzat SM, Salem MA, Merghany RM, El Mahdy NM, Kılıç CS, Sytar O, Sharifi-Rad M, Sharopov F, Martins N, Martorell M, Cho WC. Therapeutic potential of quercetin: new insights and perspectives for human health. ACS Omega 5, 11849–11872, 2020.10.1021/acsomega.0c01818725478332478277
]Search in Google Scholar
[
Shah MS, Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res 118, 1808–1829, 2016.10.1161/CIRCRESAHA.116.306923488890127230643
]Search in Google Scholar
[
Shi GJ, Li Y, Cao QH, Wu HX, Tang XY, Gao XH, Yu JQ, Chen Z, Yang Y. In vitro and in vivo evidence that quercetin protects against diabetes and its complications: a systematic review of the literature. Biomed Pharmacother 109, 1085–1099, 2019.10.1016/j.biopha.2018.10.13030551359
]Search in Google Scholar
[
Skovso S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diabetes Investig 5, 349–358, 2014.10.1111/jdi.12235421007725411593
]Search in Google Scholar
[
Takahama U, Koga Y, Hirota S, Yamauchi R. Inhibition of xanthine oxidase activity by an oxathiolanone derivative of quercetin. Food Chem 126, 1808–1811, 2011.10.1016/j.foodchem.2010.12.00925213960
]Search in Google Scholar
[
Taylor EL, Armstrong KR, Perrett D, Hattersley AT, Winyard PG. Optimization of an advanced oxidation protein products assay: its application to studies of oxidative stress in diabetes mellitus. Oxid Med Cell Longev 2015, 496271, 2015.10.1155/2015/496271446581626113954
]Search in Google Scholar
[
Torres-Piedra M, Ortiz-Andrade R, Villalobos-Molina R, Singh N, Medina-Franco JL, Webster SP, Binnie M, Navarrete-Vazquez G, Estrada-Soto S. A comparative study of flavonoid analogues on streptozotocine-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta–hydroxysteroid dehydrogenase type 1 inhibition. Eur J Med Chem 45, 2606–2616, 2010.10.1016/j.ejmech.2010.02.04920346546
]Search in Google Scholar
[
Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 301, H2181–2190, 2011.10.1152/ajpheart.00554.201121949114
]Search in Google Scholar
[
Varga ZV, Giricz Z, Liaudet L, Hasko G, Ferdinandy P, Pacher P. Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim Biophys Acta 1852, 232–242, 2015.10.1016/j.bbadis.2014.06.030427789624997452
]Search in Google Scholar
[
Wang Z, Chen K, Han Y, Zhu H, Zhou X, Tan T, Zeng J, Zhang J, Liu Y, Li Y, Yao Y, Yi J, He D, Zhou J, Ma J, Zeng C. Irisin protects heart against ischemia-reperfusion injury through a SOD2-dependent mitochondria mechanism. J Cardiovasc Pharmacol 72, 259–269, 2018.10.1097/FJC.0000000000000608628369629979350
]Search in Google Scholar
[
Wein S, Behm N, Petersen RK, Kristiansen K, Wolffram S. Quercetin enhances adiponectin secretion by a PPAR-gamma independent mechanism. Eur J Pharm Sci 1, 16–22, 2010.10.1016/j.ejps.2010.05.00420580672
]Search in Google Scholar
[
Zahedi M, Ghiasvand R, Feizi A, Asgari G, Darvish L. Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial. Int J Prev Med 4, 777–785, 2013.
]Search in Google Scholar
[
Zhang H, Xiong Z, Wang J, Zhang S, Lei L, Yang L, Zhang Z. Glucagon-like peptide-1 protects cardiomyocytes from advanced oxidation protein product-induced apoptosis via the PI3K/Akt/Bad signaling pathway. Molec Med Rep 13, 1593–1601, 2016.10.3892/mmr.2015.4724473283626717963
]Search in Google Scholar
[
Zhang M, Kho AL, Anilkumar N, Chibber R, Pagano PJ, Shah AM, Cave AC. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation 113, 1235–1243, 2006.10.1161/CIRCULATIONAHA.105.58139716505175
]Search in Google Scholar